Breast Cancer-Clinical Trials

  • Phase 1 (phase I) trials study whether a new treatment is safe to use over a range of doses. The treatment may be given to people with different types of cancers.

  • A phase 1 trial is mainly a drug safety study.

  • Phase 2 (phase II) trials study how well a treatment works for certain cancer, such as breast cancer.  These trials may include between 25 and 100 people.

  • After a drug (or other therapy) is found to be effective in treating breast cancer in a phase 2 trials, a phase 3 trial will study it further.

  • Phase 3 (phase III) trials study how well a new treatment (including surgical procedures) works compared to the standard treatment (standard of care).

  • Phase 4 (phase IV) trials study the long-term side effects of treatments or answer new questions about the treatment.

    Related Conference of Breast Cancer-Clinical Trials

    July 28-29, 2025

    45th Euro Congress on Cancer Science & Therapy

    Paris, France
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain
    October 22-23, 2025

    35th Experts Meet On Cancer Research & Therapy

    Paris, France
    October 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    Zurich, Switzerland
    November 20-21, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    November 24-25, 2025

    43rd World Cancer Conference

    Barcelona, Spain
    December 08-09, 2025

    13th Euro Breast Cancer and Therapeutics

    Aix-en-Provence, France
    February 19-20, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    February 19-20, 2026

    8th International Conference on Women Oncology

    Miami, USA
    March 23-24, 2026

    16th World Congress on Breast Cancer Research & Therapies

    Aix-en-Provence, France

    Breast Cancer-Clinical Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in